Waystar (WAY) Competitors

Waystar logo
$27.54 -0.13 (-0.47%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$27.56 +0.02 (+0.07%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WAY vs. DOCS, HTFL, SDGR, CERT, and TDOC

Should you buy Waystar stock or one of its competitors? Waystar's main competitors and comparable companies include Doximity (DOCS), Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), and Teladoc Health (TDOC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Waystar compare to Doximity?

Doximity (NYSE:DOCS) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

Doximity has a net margin of 21.12% compared to Waystar's net margin of 10.70%. Doximity's return on equity of 15.80% beat Waystar's return on equity.

Company Net Margins Return on Equity Return on Assets
Doximity21.12% 15.80% 13.38%
Waystar 10.70%6.91%4.67%

Doximity has higher earnings, but lower revenue than Waystar. Waystar is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Doximity$644.86M8.51$196.05M$0.7242.71
Waystar$1.26B4.20$112.09M$0.6939.91

Doximity has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market. Comparatively, Waystar has a beta of 0.11, meaning that its stock price is 89% less volatile than the broader market.

87.2% of Doximity shares are owned by institutional investors. 31.8% of Doximity shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Doximity had 17 more articles in the media than Waystar. MarketBeat recorded 18 mentions for Doximity and 1 mentions for Waystar. Waystar's average media sentiment score of 0.90 beat Doximity's score of 0.19 indicating that Waystar is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Doximity
2 Very Positive mention(s)
1 Positive mention(s)
14 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Doximity presently has a consensus price target of $30.59, suggesting a potential downside of 0.53%. Waystar has a consensus price target of $35.23, suggesting a potential upside of 27.91%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Doximity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Doximity
3 Sell rating(s)
14 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.20
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

Summary

Doximity beats Waystar on 11 of the 17 factors compared between the two stocks.

How does Waystar compare to Heartflow?

Waystar (NASDAQ:WAY) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Waystar currently has a consensus price target of $35.23, suggesting a potential upside of 27.91%. Heartflow has a consensus price target of $60.13, suggesting a potential upside of 31.02%. Given Heartflow's higher probable upside, analysts plainly believe Heartflow is more favorable than Waystar.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91
Heartflow
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, Heartflow had 23 more articles in the media than Waystar. MarketBeat recorded 24 mentions for Heartflow and 1 mentions for Waystar. Waystar's average media sentiment score of 0.90 beat Heartflow's score of 0.46 indicating that Waystar is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Heartflow
3 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Waystar has a beta of 0.11, suggesting that its stock price is 89% less volatile than the broader market. Comparatively, Heartflow has a beta of 2.5, suggesting that its stock price is 150% more volatile than the broader market.

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waystar$1.26B4.20$112.09M$0.6939.91
Heartflow$176.03M22.91-$116.79M-$0.92N/A

Waystar has a net margin of 10.70% compared to Heartflow's net margin of -33.11%. Waystar's return on equity of 6.91% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Waystar10.70% 6.91% 4.67%
Heartflow -33.11%-20.53%-16.81%

Summary

Waystar beats Heartflow on 10 of the 14 factors compared between the two stocks.

How does Waystar compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Waystar has a net margin of 10.70% compared to Schrodinger's net margin of -22.02%. Waystar's return on equity of 6.91% beat Schrodinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Schrodinger-22.02% -18.12% -9.07%
Waystar 10.70%6.91%4.67%

Schrodinger currently has a consensus target price of $26.67, indicating a potential downside of 1.96%. Waystar has a consensus target price of $35.23, indicating a potential upside of 27.91%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Schrodinger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schrodinger
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 3.5% of Waystar shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Schrodinger had 7 more articles in the media than Waystar. MarketBeat recorded 8 mentions for Schrodinger and 1 mentions for Waystar. Waystar's average media sentiment score of 0.90 beat Schrodinger's score of 0.76 indicating that Waystar is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Schrodinger
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schrodinger$269.20M7.59-$103.26M-$0.79N/A
Waystar$1.26B4.20$112.09M$0.6939.91

Schrodinger has a beta of 1.69, indicating that its stock price is 69% more volatile than the broader market. Comparatively, Waystar has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

Summary

Waystar beats Schrodinger on 12 of the 17 factors compared between the two stocks.

How does Waystar compare to Certara?

Certara (NASDAQ:CERT) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 3.5% of Waystar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$425.76M4.01-$1.60M-$0.42N/A
Waystar$1.26B4.20$112.09M$0.6939.91

Certara has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Waystar has a beta of 0.11, meaning that its share price is 89% less volatile than the broader market.

Waystar has a net margin of 10.70% compared to Certara's net margin of -16.14%. Waystar's return on equity of 6.91% beat Certara's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-16.14% 3.36% 2.31%
Waystar 10.70%6.91%4.67%

Certara presently has a consensus target price of $9.92, indicating a potential downside of 11.30%. Waystar has a consensus target price of $35.23, indicating a potential upside of 27.91%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

In the previous week, Certara had 1 more articles in the media than Waystar. MarketBeat recorded 2 mentions for Certara and 1 mentions for Waystar. Waystar's average media sentiment score of 0.90 beat Certara's score of 0.54 indicating that Waystar is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Waystar beats Certara on 14 of the 17 factors compared between the two stocks.

How does Waystar compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

Waystar has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.47B0.60-$200.32M-$0.86N/A
Waystar$1.26B4.20$112.09M$0.6939.91

Teladoc Health has a beta of 2, indicating that its stock price is 100% more volatile than the broader market. Comparatively, Waystar has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

Teladoc Health currently has a consensus price target of $8.53, indicating a potential upside of 5.53%. Waystar has a consensus price target of $35.23, indicating a potential upside of 27.91%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17
Waystar
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

76.8% of Teladoc Health shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 3.5% of Waystar shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Waystar has a net margin of 10.70% compared to Teladoc Health's net margin of -6.27%. Waystar's return on equity of 6.91% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.27% -11.63% -5.53%
Waystar 10.70%6.91%4.67%

In the previous week, Teladoc Health had 6 more articles in the media than Waystar. MarketBeat recorded 7 mentions for Teladoc Health and 1 mentions for Waystar. Waystar's average media sentiment score of 0.90 beat Teladoc Health's score of 0.83 indicating that Waystar is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Waystar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Waystar beats Teladoc Health on 13 of the 17 factors compared between the two stocks.

Get Waystar News Delivered to You Automatically

Sign up to receive the latest news and ratings for WAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WAY vs. The Competition

MetricWaystarHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$5.32B$1.92B$7.72B$11.67B
Dividend YieldN/A3.89%2.47%4.53%
P/E Ratio39.9139.4132.3627.90
Price / Sales4.205.208.285.57
Price / Cash14.2015.5120.8521.62
Price / Book1.314.594.443.72
Net Income$112.09M-$19.09M$3.51B$394.03M
7 Day Performance-2.13%-7.41%-4.69%-4.67%
1 Month Performance-1.61%-7.56%-5.66%-7.21%
1 Year Performance-20.86%-11.73%-1.17%-7.05%

Waystar Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WAY
Waystar
4.1932 of 5 stars
$27.54
-0.5%
$35.23
+27.9%
-21.0%$5.32B$1.26B39.911,700
DOCS
Doximity
2.5653 of 5 stars
$32.45
-1.3%
$30.45
-6.2%
N/A$5.78B$655.57M45.07880
HTFL
Heartflow
3.8467 of 5 stars
$55.80
-1.5%
$48.63
-12.9%
+68.0%$4.85B$176.03MN/A843
SDGR
Schrodinger
2.0077 of 5 stars
$32.41
-2.9%
$26.67
-17.7%
+59.9%$2.39B$255.87MN/A850
CERT
Certara
1.7232 of 5 stars
$12.13
-0.7%
$9.92
-18.2%
+37.5%$1.85B$418.84MN/A1,576

Related Companies and Tools


This page (NASDAQ:WAY) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners